Directory and Use of Names Sample Clauses

Directory and Use of Names. (a) Blue Shield shall develop a directory of Primary Care Physicians and certain specialists and other healthcare providers participating in Blue Shield which shall be distributed to Members. Blue Shield may provide a draft of such directory to Group and Group may, within five (5) working days thereafter, submit to Blue Shield, any additions, deletions, or modifications to be included in the directory. Group, on behalf of itself and each of its Group Providers, agrees that the following information may be included in Blue Shield’s marketing materials, Blue Shield publications provided to present or potential Members and subscriber groups, and in other written or electronic information sources provided to present or potential Members and subscriber groups: (i) Group’s name, address, phone number; (ii) the names, addresses, phone numbers, areas of practice of its Group Providers (and other provider specific information); and, (iii) such other types of information regarding Group and Group Providers which are reasonable to include in directories, marketing materials, or publications. Group and Group Providers agree that in the event this Agreement is terminated, or the listing information is or becomes incorrect or incomplete, Blue Shield will have no obligation to correct, delete, or update such listing information until such time as Blue Shield, in its sole discretion, issues a new directory, marketing material, or Blue Shield publication.
AutoNDA by SimpleDocs
Directory and Use of Names. Blue Shield maintains a directory of healthcare providers participating in Blue Shield which may be distributed and/or made available to Members. Provider agrees that the following information may be included in Blue Shield’s marketing materials, Blue Shield publications provided to current or potential Members and subscriber groups, and in other written or electronic information sources: (a) Provider’s name, practice location or locations, and contact information, including open and closed panel status for PCPs; (b) type of practitioner; (c) National Provider Identifier number; (d) California license number and type of license; (e) area of specialty, including board certification, if any; (f) Provider’s office email address, if available; (g) For physicians, surgeons, and podiatrists, the admitting privileges, if any, at hospitals contracted with the insurer; and (h) such other types of information regarding Provider that are reasonable to include in directories, marketing materials, or publications. Blue Shield shall maintain said directory pursuant to state and federal law, including, but not limited to, Health & Safety Code 1367.27. Provider may identify himself/herself/itself as a participating/contracting provider with Blue Shield in all Benefit Programs and Tiered/Narrow Products in which he/she/it participates.
Directory and Use of Names. Blue Shield maintains a directory of healthcare providers participating in Blue Shield which may be distributed and/or made available to Members. Provider agrees that the following information may be included in Blue Shield’s marketing materials, Blue Shield publications provided to current or potential Members and subscriber groups, and in other written or electronic information sources: (a) Provider’s name, practice location or locations, and contact information, including open and closed panel status for PCPs; (b) type of practitioner; (c) National Provider Identifier number; (d) California license number and type of license; (e) area of specialty, including board certification, if any; (f) Provider’s office email address, if available; (g) For physicians, surgeons, and podiatrists, the admitting privileges, if any, at hospitals contracted with the insurer; and (h) such other types of information regarding Provider that are reasonable to include in directories, marketing materials, or publications. Blue Shield shall maintain said directory pursuant to state and federal law, including, but not limited to, Health & Safety Code 1367.27. Blue Shield may engage a vendor or vendors that performs some or most of Blue Shield’s provider directory maintenance tasks of behalf of Blue Shield (“Directory Vendor”). Blue Shield shall identify the Directory Vendor to Provider and, throughout the term of this Agreement, Provider shall maintain a participation agreement with such Directory Vendor to facilitate exchange of directory data about Provider. With respect to provisions of this Agreement pertaining to Blue Shield’s provider directory, Provider shall be equally obligated to respond and otherwise cooperate with either Directory Vendor or Blue Shield itself, as Blue Shield directs. Provider may identify himself/herself/itself as a participating/contracting provider with Blue Shield in all Benefit Programs and Tiered/Narrow Products in which he/she/it participates.
Directory and Use of Names. Blue Shield from time to time may develop a directory of healthcare providers participating in Blue Shield which may be distributed and/or made available to Members. Provider agrees that the following information may be included in Blue Shield’s marketing materials, Blue Shield publications provided to current or potential Members and subscriber groups, and in other written or electronic information sources: (a) Provider’s name, address, phone number; and, (b) such other types of information regarding Providers which are reasonable to include in directories, marketing materials, or publications. Provider agrees that in the event this Agreement is terminated, or the listing information is or becomes incorrect or incomplete, Blue Shield will have no obligation to correct, delete, or update such listing information until such time as Blue Shield, in its sole discretion and in compliance with the Xxxx-Xxxxx Act, issues a new directory, marketing materials, or Blue Shield publication. Provider may identify himself/herself/itself as a participating/contracting provider with Blue Shield in all Benefit Programs and Tiered/Narrow Products in which he/she/it participates.
Directory and Use of Names. Each Health Plan maintains a directory of Health Plan Providers participating in Health Plan that is made available to Members. Provider agrees that the following information may be included in Health Plan’s marketing materials, Health Plan publications provided to current or potential Members and subscriber groups, and in other written or electronic information sources: (a) Provider’s name, practice location or locations, and contact information, including open and closed panel status for PCPs; (b) type of practitioner; (c) National Provider Identifier number; (d) California license number and type of license; (e) area of specialty, including board certification, if any; (f) Provider’s office email address, if available; (g) For physicians, surgeons, and podiatrists, the admitting privileges, if any, at hospitals contracted with the insurer; and (h) such other types of information regarding Provider that are reasonable to include in directories, marketing materials, or publications. The Plans shall maintain said directory pursuant to state and federal law, including, but not limited to, Section 116 of the Consolidated Appropriations Act of 2021, Health and Safety Code 1367.27 and 42 C.F.R. Section 438.10. Health Plan may engage a vendor or vendors that performs some or most of Health Plan’s provider directory maintenance tasks of behalf of Health Plan (“Directory Vendor”). Health Plan shall identify any such Directory Vendor to Provider and, throughout the term of this Agreement, Provider shall maintain a participation agreement with such Directory Vendor to facilitate exchange of directory data about Provider. With respect to provisions of this Agreement pertaining to Health Plan’s provider directory, Provider shall be equally obligated to respond and otherwise cooperate with either Directory Vendor or Health Plan itself, as Health Plan directs. Provider may identify himself/herself/itself as a participating/contracting provider with Health Plan in all Benefit Programs and Tiered/Narrow Products in which he/she/it participates.

Related to Directory and Use of Names

  • Use of Names The Manager and the Fund agree that the Manager has a proprietary interest in the names “DFA” and “Dimensional,” and that the Fund and/or Portfolio may use such names only as permitted by the Manager, and the Fund further agrees to cease use of such names promptly after receipt of a written request to do so from the Manager.

  • NON-USE OF NAMES Neither Party shall use the name of the other Party, nor any adaptation thereof, in any advertising, promotional or sales literature without prior written consent obtained from such other Party in each case (which consent shall not be unreasonably withheld or delayed).

  • Publicity/Use of Names Neither Party shall use the name, trademark, trade name or logo of the other Party, its Affiliates or their respective employee(s) in any publicity, promotion, news release or disclosure relating to this Agreement or its subject matter, without the prior express written permission of the other Party, except for those disclosures expressly authorized under this Article 4. Following execution of this Agreement, either Party may issue a press release announcing the existence of this Agreement in form and substance agreed to in writing by both Parties, such agreement to not be unreasonably withheld or delayed. Each Party agrees not to issue any other press release or other public statement disclosing other information relating to this Agreement or the transactions contemplated hereby without the prior written consent of the other Party, which consent shall not be unreasonably withheld or delayed; provided that Arvinas agrees that it shall be deemed reasonable for Pfizer to withhold its consent for the disclosure of any information related to a Target or a specific Compound or the amount of any payment made or to be made under this Agreement; and provided further that any disclosure which is required by Law or the rules of a securities exchange, as reasonably advised by the disclosing Party’s counsel, may be made subject to the following. Each Party agrees to provide to the other Party a copy of any public announcement regarding this Agreement or the subject matter thereof as soon as reasonably practicable under the circumstances prior to its scheduled release. Except under extraordinary circumstances or to the extent any such advance notice or notice period is not consistent with applicable Law, each Party shall provide the other with an advance copy of any such announcement at least [**] prior to its scheduled release. Each Party shall have the right to expeditiously review and recommend changes to any such announcement and, except as otherwise required by Law, the Party whose announcement has been reviewed shall remove any information the reviewing Party reasonably deems to be inappropriate for disclosure. The contents of any announcement or similar publicity which has been reviewed and approved by the reviewing Party can be re-released by either Party without a requirement for re-approval. In addition, except to the extent required by Laws in connection with patent enforcement activities conducted in accordance with Article 7, Pfizer shall not use the name “Yale” or “Yale University,” nor any variation or adaptation thereof, nor any trademark, trade name or other designation owned by Yale University, nor the names of any of its trustees, officers, faculty, students, employees or agents, for any purpose without the prior written consent of Yale University in each instance, such consent to be granted or withheld by Yale University in its sole discretion, except that Pfizer may state that it has sublicensed from Yale University one or more of the patents or applications comprising the Yale Licensed Patents.

  • No Use of Name Supplier shall not use, or permit the use of, the name, trade name, service marks, trademarks, or logo of EY or of any EY Network Member in any form of publicity, press release, advertisement, or otherwise without EY’s prior written consent.

  • Use of Name (a) The Sub-Adviser hereby consents to the use of its name and the names of its affiliates in the Fund’s disclosure documents, shareholder communications, advertising, sales literature and similar communications. The Sub-Adviser shall not use the name or any tradename, trademark, trade device, service xxxx, symbol or any abbreviation, contraction or simulation thereof of the Adviser, the Trust, the Fund or any of their affiliates in its marketing materials unless it first receives prior written approval of the Trust and the Adviser.

  • RESERVATION OF NAME The Investment Adviser shall at all times have all rights in and to the Portfolio’s name and all investment models used by or on behalf of the Portfolio. The Investment Adviser may use the Portfolio’s name or any portion thereof in connection with any other mutual fund or business activity without the consent of any shareholder and the Fund shall execute and deliver any and all documents required to indicate the consent of the Fund to such use. The Fund hereby agrees that in the event that neither the Investment Adviser nor any of its affiliates acts as investment adviser to the Portfolio, the name of the Portfolio will be changed to one that does not suggest an affiliation with the Investment Adviser.

  • USE OF NAMES AND TRADEMARKS 9.1 Nothing contained in this Agreement confers any right to use in advertising, publicity, or other promotional activities any name, trade name, trademark, or other designation of either party hereto (including contraction, abbreviation or simulation of any of the foregoing). Unless required by law, the use by LICENSEE of the name, “The Regents Of The University Of California” or the name of any campus of the University Of California is prohibited, without the express written consent of UNIVERSITY.

  • Use of Names; Publicity The Trust shall not use the Distributor’s name in any offering material, shareholder report, advertisement or other material relating to the Trust, other than for the purpose of merely identifying and describing the functions of the Distributor hereunder, in a manner not approved by the Distributor in writing prior to such use, such approval not to be unreasonably withheld. The Distributor hereby consents to all uses of its name required by the SEC, any state securities commission, or any federal or state regulatory authority. The Distributor shall not use the name “Tidal ETF Trust” in any offering material, shareholder report, advertisement or other material relating to the Distributor, other than for the purpose of merely identifying the Trust as a client of Distributor hereunder, in a manner not approved by the Trust in writing prior to such use; provided, however, that the Trust shall consent to all uses of its name required by the SEC, any state securities commission, or any federal or state regulatory authority; and provided, further, that in no case shall such approval be unreasonably withheld. The Distributor will not issue any press releases or make any public announcements regarding the existence of this Agreement without the express written consent of the Trust. Neither the Trust nor the Distributor will disclose any of the economic terms of this Agreement, except as may be required by law.

Time is Money Join Law Insider Premium to draft better contracts faster.